A Phase I, randomized, controlled, dose escalating, single blind, clinical trial to assess the safety, tolerability and immunogenicity of Bivalent (JAIVAC-2: PfMSPFu24 +PfF2/ Alhydrogel) P. falciparum malaria vaccine in malaria naive healthy Indian adult males
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Bivalent malaria vaccine-Novavax/CPL Biologicals/ICGEB (Primary) ; Aluminium hydroxide; Hepatitis B vaccine
- Indications Falciparum malaria
- Focus Adverse reactions
Most Recent Events
- 18 Jun 2020 New trial record